Harald Schmidt

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

Rüdiger Göke, H. C. Fehmann, Thomas Linn et al. · Journal of Biological Chemistry · 1993 · 834 citations · Full text

Cross-linking Experiments, Glycobiology, Peptide Science +20

Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2

Jean‐Pierre Gutzwiller, Jürgen Drewe, Burkhard Göke et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1999 · 526 citations

Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study

Heyder Omran, Harald Schmidt, M. H. Hackenbroch et al. · The Lancet · 2003 · 416 citations

Aortic Valve, Endovascular Technique, Valvular Stenosis +9

Patients With Atrial Fibrillation and Dense Spontaneous Echo Contrast at High Risk

Peter Bernhardt, Harald Schmidt, Christoph Hammerstingl et al. · Journal of the American College of Cardiology · 2005 · 180 citations

Radiology, Cardiovascular Disease, High Risk +6

Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells

Sabine Fuchs, Xin Jiang, Harald Schmidt et al. · Biomaterials · 2008 · 161 citations

Regenerative Medicine, Tissue Engineering, Mechanobiology +14